Novavax to start Phase 1 trials for COVID-19 vaccine next month [MarketWatch]
Novavax, Inc. (NVAX)
Last novavax, inc. earnings: 3/11 04:17 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.novavax.com/investor-relations
Company Research
Source: MarketWatch
Shares of Novavax Inc. jumped 9% in premarket trading on Wednesday after the company said it had identified a COVID-19 vaccine candidate. There are no approved vaccines for the novel coronavirus. Novavax said it plans to begin Phase 1 clinical trials in mid-May for the candidate, which "produces high levels of neutralizing antibodies against SARS-CoV-2 in animal studies," Novavax president of R&D Gregory Glenn said in a statement. The first phase of the placebo-controlled study will enroll 130 healthy adults; the first round of data from that study is expected in July. Novavax in March said it had received $4 million from the Coalition for Epidemic Preparedness Innovations, a global organization that has provided millions of dollars in funding to vaccine makers during the pandemic. Year-to-date, Novavax's stock has soared 274%, while the S&P 500 has dropped 17%.
Show less
Read more
Impact Snapshot
Event Time:
NVAX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVAX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVAX alerts
High impacting Novavax, Inc. news events
Weekly update
A roundup of the hottest topics
NVAX
News
- 2 Growth Stocks with Explosive Upside and 1 That Underwhelm [Yahoo! Finance]Yahoo! Finance
- JPM26: Matrix-M Technology is central to Novavax's strategy [Yahoo! Finance]Yahoo! Finance
- 85 years of bold discovery: Texas Biomed marks milestone anniversary [Yahoo! Finance]Yahoo! Finance
- Novavax to Participate in the 44th Annual J.P. Morgan Healthcare ConferencePR Newswire
- Is Novavax (NVAX) Mispriced After Recent Share Rebound And DCF Upside Projection [Yahoo! Finance]Yahoo! Finance
NVAX
Earnings
- 11/6/25 - Miss
NVAX
Sec Filings
- 1/12/26 - Form 8-K
- 12/15/25 - Form 4
- 11/12/25 - Form SCHEDULE
- NVAX's page on the SEC website